Panteli Theocharous

Panteli Theocharous serves as the Chief Therapeutics Officer and Head of Medical and Scientific Affairs at Garuda Therapeutics, overseeing global medical affairs activities for investigational products since July 2023. Prior experience includes roles as Global Vice President at PPD, where responsibilities encompassed leading cell and gene therapy strategy and serving as Chief Medical Officer for biopharmaceutical clients. Earlier, Theocharous co-founded Cell Therapeutics, Inc., and was instrumental in developing its European business division and medical affairs strategy. At The Janssen Pharmaceutical Companies of Johnson & Johnson, significant contributions included leading haematology/oncology R&D efforts and securing pivotal drug approvals. Notably, a Head position at Onyvax involved managing prostate cancer vaccine development and raising substantial funding for research. Educational credentials include a Higher Medical Degree from the University of London and a Ph.D. in Clinical Cancer Medicine from UCL Cancer Institute.